Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 32, Issue 3, 2008, Pages 755-760

  Fujikawa, Midori ^a,b   Togo, Takashi ^a   Yoshimi, Asuka ^c   Fujita, Junichi ^d   Nomoto, Munetaka ^d   Kamijo, Atsushi ^a   Amagai, Toru ^a   Uchikado, Hirotake ^b   Katsuse, Omi ^b   Hosojima, Hideki ^e   Sakura, Yoshihisa ^f   Furusho, Ryo ^g   Suda, Akira ^g   Yamaguchi, Takayuki ^h   Hori, Taketo ^a   Kamada, Ayuko ^g   Kondo, Taizo ^g   Ito, Michitomo ^e   Odawara, Toshinari ^g   Hirayasu, Yoshio ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b Yokohama Maioka Hospital   (Japan)

^c Washin Zaka Hospital   (Japan)

^d Kanagawa Psychiatric Center   (Japan)

^e Higashi Kanagawa Clinic   (Japan)

^f Yokohama Minami Kyosai Hospital   (Japan)

^g YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^h NTT Higashi Nihon Izu Hospital   (Japan)

Author keywords

Adherence; Schizophrenia; Subjective treatment satisfaction; TSQM

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; ANTIPARKINSON AGENT; BENZODIAZEPINE; BIPERIDEN; BROMPERIDOL; HALOPERIDOL; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; PEROSPIRONE; QUETIAPINE; RISPERIDONE; TIMIPERONE; TRIHEXYPHENIDYL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PATIENT COMPLIANCE; PATIENT SATISFACTION; PSYCHIATRIC TREATMENT; SCHIZOPHRENIA; UNSPECIFIED SIDE EFFECT;

ADULT; ANALYSIS OF VARIANCE; ANTIPSYCHOTIC AGENTS; CHI-SQUARE DISTRIBUTION; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; QUESTIONNAIRES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 39749179820     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2007.12.002     Document Type: Article

References (23)

1. Adewuya A.O., Ola B.A., Mosaku S.K., Fatoye F.O., and Eegunranti A.B. Attitude towards antipsychotics among out-patients with schizophrenia in Nigeria. Acta Psychiatr Scand 113 (2006) 207-211
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorder. 4th ed (1994), American Psychiatric Association, Washington, DC
3. Atkinson M.J., Sinha A., Hass S.L., Colman S.S., Kumar R.N., Brod M., et al. Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease. Health and Quality of Life Outcomes 26 2 (2004) 12
4. Diaz E., Neuse E., Sullivan M.C., Pearsall H.R., and Woods S.W. Adherence to conventional and atypical antipsychotics after hospital discharge. J Clin Psychiatry 65 (2004) 354-360
5. Dolder C.R., Lacro J.P., Dunn L.B., and Jeste D.V. Antipsychotic medication adherence: is there a difference between typical and atypical agents. Am J Psychiatry 159 (2002) 103-108
6. Freudenreich O., Cather C., Evins A.E., Henderson D.C., and Goff D.C. Attitudes of schizophrenia outpatients toward psychiatric medications: relationship to clinical variables and insight. J Clin Psychiatry 65 (2004) 1372-1376
7. Hogan T.P., Awad A.G., and Eastwood R. A self-report scale predictive of drug compliance in schizophrenics: reliability and discriminative validity. Psychol Med 13 (1983) 177-183
8. Inada T., Beasley Jr. C.M., Tanaka Y., and Walker D.J. Extrapyramidal symptom profiles assessed with the Drug-induced Extrapyramidal Symptom Scale: comparison with Western scales in the clinical double-blind studies of schizophrenic patients treated with either olanzapine or haloperidol. Int Clin Psychopharmacol 18 (2003) 39-48
9. Jones P.B., Barnes T.R., Davies L., Dunn G., Lloyd H., Hayhurst K.P., et al. Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1). Arch Gen Psychiatry 63 (2006) 1079-1087
10. Karow A., Czekalla J., Dittmann R.W., Schacht A., Wagner T., Lambert M., et al. Association of subjective well-being, symptoms, and side effects with compliance after 12 months of treatment in schizophrenia. J Clin Psychiatry 68 (2007) 75-80
11. Kim S.W., Shin I.S., Kim J.M., Yang S.J., Shin S.J., and Yoon J.S. Association between attitude toward medication and neurocognitive function in schizophrenia. Clin Neuropharmacol 29 (2006) 197-205
12. Lambert M., Schimmelmann B.G., Naber D., Schacht A., Karow A., Wagner T., et al. Prediction of remission as a combination of symptomatic and functional remission and adequate subjective well-being in 2960 patients with schizophrenia. J Clin Psychiatry 67 (2006) 1690-1697
13. Leucht S., and Heres S. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. J Clin Psychiatry 67 Suppl 5 (2006) 3-8
14. Loffler W., Kilian R., Toumi M., and Angermeyer M.C. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment. Pharmacopsychiatry 36 (2003) 105-112
15. Menzin J., Boulanger L., Friedman M., Mackell J., and Lloyd J.R. Treatment adherence associated with conventional and atypical antipsychotics in a large state Medicaid program. Psychiatr Serv 54 (2003) 719-723
16. Overall J.E., and Gorham D.R. The brief psychiatric rating scale. Psychol Rep 10 (1962) 799-812
17. Robinson D., Woerner M.G., Alvir J.M., Bilder R., Goldman R., Geisler S., et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 5 (1999) 241-247
18. Taira M., Hashimoto T., Takamatsu T., and Maeda K. Subjective response to neuroleptics: the effect of a questionnaire about neuroleptic side effects. Prog Neuropsychopharmacol Biol Psychiatry 30 (2006) 1139-1142
19. Thompson K., Kulkarni J., and Sergejew A.A. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophr Res 42 (2000) 241-247
20. Velligan D.I., Lam Y.W., Glahn D.C., Barrett J.A., Maples N.J., Ereshefsky L., et al. Defining and assessing adherence to oral antipsychotics: a review of the literature. Schizophr Bull 32 (2006) 724-742
21. Voruganti L., Cortese L., Oyewumi L., Cernovsky Z., Zirul S., and Awad A. Comparative evaluation of conventional and novel antipsychotic drugs with reference to their subjective tolerability, side-effect profile and impact on quality of life. Schizophr Res 43 (2000) 135-145
22. Wehmeier P.M., Kluge M., Schneider E., Schacht A., Wagner T., and Schreiber W. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 31 (2007) 703-712
23. Wehmeier P.M., Kluge M., Schacht A., Helsberg K., and Schreiber W. Correlation of physician- and patient-rated quality of life during antipsychotic treatment in outpatients with schizophrenia. Schizophr Res 91 (2007) 178-186